Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Louisville MSD customers in Jefferson and Oldham counties could see higher prices starting in Summer 2025.

For the new graduates at the Maryland School for the Deaf, Friday’s commencement ceremony was the culmination of a year of big plans and accomplishments. The school’s theme for the past year was ...

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

The Louisville MSD Board approved a preliminary rate increase Tuesday, saying it's going to protect public health, property ...

There will now be a 30-day comment period and the board will vote on the final rate resolution on July 28, with the rates ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

ORION CORPORATION INVESTOR NEWS 21 MAY 2025 at 07.30 EEST Orion’s collaborator, MSD, expands clinical development program for ...

The agency says the rate hike is to support major infrastructure investments to protect public health, property and the environment across its service area.

Louisville MSD board members voted to approve a preliminary rate increase. If approved, the rate increase would add $3.91 to the average monthly bill for customers in Jefferson County and $1.57 ...